Form S-1/A PALVELLA THERAPEUTICS,
Tweet
Share
E-mailhttp://archive.fast-edgar.com/20250114/AKZZU22CZ22292Z2222822ZZNOOPZ6R8GA72
Filed on: January 14, 2025
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Csquare prices IPO at $21 per share on NYSE
- Celea Therapeutics doses first patient in phase 3 IPF drug trial
- AEON Biopharma prices $13.75M public offering with milestone warrants
Create E-mail Alert Related Categories
SEC FilingsRelated Entities
S1Sign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
